Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Percival D Sampaio-Barros

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
The American Journal of the Medical Sciences|March 2, 2011
Epidemiology of spondyloarthritis in BrazilPercival D Sampaio-Barros
Rheumatic Diseases Clinics of North America|April 20, 2013
SAPHO syndromeSueli Carneiro, Percival D Sampaio-Barros
Best Practice & Research. Clinical Rheumatology|December 10, 2014
Adverse effects of TNF inhibitors in SpA: are they different from RA?Percival D Sampaio-Barros, Irene E van der Horst-Bruinsma
Current Rheumatology Reports|July 16, 2014
Seronegative arthritis in Latin America: a current reviewCarla Gonçalves Schain Saad, Célio Roberto Gonçalves, Percival D Sampaio-Barros
Rheumatology International|September 8, 2006
Characterization and outcome of uveitis in 350 patients with spondyloarthropathiesPercival D Sampaio-Barros, Roseneide A Conde, Rubens Bonfiglioli, et al.
Revista Brasileira De Reumatologia|August 2, 2016
Low vitamin D serum levels in diffuse systemic sclerosis: a correlation with worst quality of life and severe capillaroscopic findingsMarília M Sampaio-Barros, Liliam Takayama, Percival D Sampaio-Barros, et al.
Clinical Rheumatology|May 9, 2019
Clinical and laboratory features of African-Brazilian patients with systemic sclerosisCristiane Mendes, Vilma S T Viana, Sandra G Pasoto, et al.
Clinical Rheumatology|November 6, 2007
Frequency of HLA-B27 alleles in Brazilian patients with psoriatic arthritisRubens Bonfiglioli, Roseneide A Conde, Percival D Sampaio-Barros, et al.
Nature Reviews. Rheumatology|September 15, 2025
Global epidemiology of spondyloarthritisJohn D Reveille, Lihi Eder, Nelly Ziade, et al.
International Journal of Molecular Medicine|October 9, 2012
Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1Andreea M Bujor, Paul Haines, Cristina Padilla, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
The American Journal of the Medical Sciences|March 2, 2011
Epidemiology of spondyloarthritis in BrazilPercival D Sampaio-Barros
Rheumatic Diseases Clinics of North America|April 20, 2013
SAPHO syndromeSueli Carneiro, Percival D Sampaio-Barros
Best Practice & Research. Clinical Rheumatology|December 10, 2014
Adverse effects of TNF inhibitors in SpA: are they different from RA?Percival D Sampaio-Barros, Irene E van der Horst-Bruinsma
Current Rheumatology Reports|July 16, 2014
Seronegative arthritis in Latin America: a current reviewCarla Gonçalves Schain Saad, Célio Roberto Gonçalves, Percival D Sampaio-Barros
Rheumatology International|September 8, 2006
Characterization and outcome of uveitis in 350 patients with spondyloarthropathiesPercival D Sampaio-Barros, Roseneide A Conde, Rubens Bonfiglioli, et al.
Revista Brasileira De Reumatologia|August 2, 2016
Low vitamin D serum levels in diffuse systemic sclerosis: a correlation with worst quality of life and severe capillaroscopic findingsMarília M Sampaio-Barros, Liliam Takayama, Percival D Sampaio-Barros, et al.
Clinical Rheumatology|May 9, 2019
Clinical and laboratory features of African-Brazilian patients with systemic sclerosisCristiane Mendes, Vilma S T Viana, Sandra G Pasoto, et al.
Clinical Rheumatology|November 6, 2007
Frequency of HLA-B27 alleles in Brazilian patients with psoriatic arthritisRubens Bonfiglioli, Roseneide A Conde, Percival D Sampaio-Barros, et al.
Nature Reviews. Rheumatology|September 15, 2025
Global epidemiology of spondyloarthritisJohn D Reveille, Lihi Eder, Nelly Ziade, et al.
International Journal of Molecular Medicine|October 9, 2012
Ciprofloxacin has antifibrotic effects in scleroderma fibroblasts via downregulation of Dnmt1 and upregulation of Fli1Andreea M Bujor, Paul Haines, Cristina Padilla, et al.
Pageof 7